9 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LABSYSTEMS UNISKAN

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

AQUAPAK NEBULIZER ADAPTORS/RESERVOIRS

FDA 510(k)
FDA Class 2 ·Anesthesiology

PASCO MIC AND MIC/ID PANELS

FDA 510(k)
FDA Class 2 ·Microbiology

EXTENSION SET 30IN

FDA Adverse Event
Malfunction ·HOSPIRA INC.·Product code FPA·June 3, 2009

APM/AIM PUMP SET W/C

FDA Adverse Event
Malfunction ·HOSPIRA COSTA RICA LTD.·Product code FPA·September 28, 2010

RESTORE ULTRA

FDA Adverse Event
Injury ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code LGW·May 30, 2014

CLICK X

FDA Adverse Event
Injury ·SYNTHES USA·Product code NKB·November 21, 2012

SPECIALTY XIA II SHAFT

FDA Adverse Event
Malfunction ·STRYKER SPINE BORDEAUX·Product code LXH·September 7, 2010

Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), product code 35700BAX - Product Usage: The Baxter SIGMA Spectrum Infusion Pump with Master Drug Library is intended to be used for the controlled administration of fluids. These fluids may include pharmaceutical drugs, blood, blood products and mixture of required patient therapy. The intended routes of administration consist of the following clinically accepted routes: intravenous, arterial, subcutaneous, intrathecal, epidural or irrigation of fluid space. Spectrum Infusion Pump is intended to be used in conjunction with legally marketed intravenous administration sets and medications provided by the user. The Spectrum and Spectrum with Master Drug Library is suitable for many user facility applications such as but not limited to hospitals, outpatient care areas, homecare and ambulatory care services. Spectrum and Spectrum with Master Drug Library is intended to reduce operator interaction through automated programming thereby helping to reduce errors associated with complex device programming. Parameter programming requires trained healthcare professional confirmation of limits and drug therapy to the physician s directive.

FDA Enforcement
Class II ·Terminated·Baxter Healthcare Corporation·May 8, 2019